Lippis Daniel J.
SEC CIK 2004380 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EW | Edwards Lifesciences | CVP, TAVR | 40.7K | — | $1.93M | 64 | 2024-02-16 | 2026-09-11 |
Most active insiders at EW, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOBO DONALD E JR | CVP, Strategy, Corp Development | — | $11.15M |
| 2 | Zovighian Bernard J | CEO, Dir | — | $7.00M |
| 3 | Ullem Scott B. | CFO, CVP | — | $3.87M |
| 4 | Chopra Daveen | CVP, TMTT, Surgical, IHFM | — | $3.19M |
| 5 | Markowitz Wayne | CVP, JAPAC | — | $1.04M |
| 6 | Lippis Daniel J. | CVP, TAVR | — | $871.6K |
| 7 | Bruls Annette | CVP, EMEACLA | — | $237.9K |
| 8 | STONE HEISZ LESLIE | Dir | — | $218.1K |
| 9 | Dahl Andrew M. | SVP, Corp. Ctrl | — | $98.4K |
| 10 | Davis Leslie C. | Dir | — | — |
Transactions 64
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-11 19:15 | 2026-09-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +619 | 40.7K | +2% | +$45.0K |
| DT | 2026-09-11 19:15 | 2026-09-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $87.51 | -619 | 40.0K | -2% | -$54.2K |
| DT | 2026-08-11 17:07 | 2026-08-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +619 | 40.7K | +2% | +$45.0K |
| DT | 2026-08-11 17:07 | 2026-08-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $92.03 | -619 | 40.0K | -2% | -$57.0K |
| DT | 2026-07-10 17:04 | 2026-07-10 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +619 | 40.7K | +2% | +$45.0K |
| DT | 2026-07-10 17:04 | 2026-07-10 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $91.70 | -619 | 40.0K | -2% | -$56.8K |
| 2026-07-07 18:56 | 2026-07-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | F - Tax | $95.18 | -377 | 40.0K | -0.9% | -$35.9K | |
| DT | 2026-06-30 20:01 | 2026-06-30 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +619 | 41.0K | +2% | +$45.0K |
| DT | 2026-06-30 20:01 | 2026-06-30 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $91.40 | -619 | 40.4K | -2% | -$56.6K |
| DT | 2026-05-18 17:29 | 2026-05-18 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | M - OptEx | $72.68 | +620 | 41.0K | +2% | +$45.1K |
| DT | 2026-05-18 17:29 | 2026-05-18 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $81.14 | -620 | 40.4K | -2% | -$50.3K |
| 2026-05-11 21:32 | 2026-05-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | F - Tax | $79.96 | -362 | 40.4K | -0.9% | -$28.9K | |
| D | 2026-05-08 21:16 | 2026-05-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | A - Grant | $0.00 | +7,850 | 41.5K | +23% | $0 |
| DM | 2026-05-08 21:16 | 2026-05-07+ | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | F - Tax | $82.94 | -759 | 40.8K | -2% | -$63.0K |
| DMT | 2026-05-04 19:30 | 2026-05-01+ | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | M - OptEx | $59.26 | +2,038 | 34.7K | +6% | +$120.8K |
| DMT | 2026-05-04 19:30 | 2026-05-01+ | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $83.49 | -2,038 | 33.7K | -6% | -$170.2K |
| DT | 2026-05-04 19:30 | 2026-05-03 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | F - Tax | $83.98 | -252 | 33.7K | -0.7% | -$21.2K |
| DT | 2026-04-06 20:42 | 2026-04-06 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | M - OptEx | $59.26 | +1,019 | 35.0K | +3% | +$60.4K |
| DT | 2026-04-06 20:42 | 2026-04-06 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $80.98 | -1,019 | 33.9K | -3% | -$82.5K |
| D | 2026-03-11 | 2026-03-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | M - OptEx | $59.26 | +1,019 | 35.0K | +3% | +$60.4K |
| D | 2026-03-11 | 2026-03-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $85.38 | -1,019 | 33.9K | -3% | -$87.0K |
| 2026-02-23 | 2026-02-22 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | F - Tax | $79.78 | -432 | 33.9K | -1% | -$34.5K | |
| M | 2026-02-17 | 2026-02-16+ | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | F - Tax | $75.87 | -456 | 34.6K | -1% | -$34.6K |
| 2026-02-17 | 2026-02-12 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | A - Grant | $0.00 | +12.8K | 34.8K | +58% | $0 | |
| D | 2026-01-09 | 2026-01-09 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | S - Sale+OE | $85.70 | -1,019 | 22.0K | -4% | -$87.3K |
| D | 2026-01-09 | 2026-01-09 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, TAVR | M - OptEx | $59.26 | +1,019 | 23.0K | +5% | +$60.4K |
| D | 2025-12-12 | 2025-12-12 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $59.26 | +1,019 | 23.0K | +5% | +$60.4K |
| D | 2025-12-12 | 2025-12-12 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $84.03 | -1,019 | 22.0K | -4% | -$85.6K |
| D | 2025-11-10 | 2025-11-10 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $59.26 | +1,020 | 23.0K | +5% | +$60.4K |
| D | 2025-11-10 | 2025-11-10 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $82.55 | -1,020 | 22.0K | -4% | -$84.2K |
| 2025-07-28 | 2025-07-28 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale | $79.46 | -4,114 | 22.0K | -16% | -$326.9K | |
| 2025-07-07 | 2025-07-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | F - Tax | $76.79 | -333 | 26.1K | -1% | -$25.6K | |
| 2025-05-12 | 2025-05-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | F - Tax | $73.68 | -271 | 26.3K | -1% | -$20.0K | |
| D | 2025-05-09 | 2025-05-09 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $74.42 | -330 | 26.6K | -1% | -$24.6K |
| D | 2025-05-09 | 2025-05-09 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +330 | 26.9K | +1% | +$14.9K |
| D | 2025-05-09 | 2025-05-08 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | A - Grant | $0.00 | +4,225 | 26.6K | +19% | $0 |
| M | 2025-05-05 | 2025-05-03+ | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | F - Tax | $75.65 | -472 | 22.6K | -2% | -$35.7K |
| D | 2025-04-08 | 2025-04-08 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +300 | 23.2K | +1% | +$13.6K |
| D | 2025-04-08 | 2025-04-08 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $70.61 | -300 | 22.9K | -1% | -$21.2K |
| D | 2025-03-10 | 2025-03-10 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $69.48 | -400 | 22.6K | -2% | -$27.8K |
| D | 2025-03-10 | 2025-03-10 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +400 | 23.0K | +2% | +$18.1K |
| M | 2025-02-18 | 2025-02-16+ | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | F - Tax | $76.19 | -601 | 22.6K | -3% | -$45.8K |
| D | 2025-02-13 | 2025-02-13 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +500 | 23.7K | +2% | +$22.6K |
| D | 2025-02-13 | 2025-02-13 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $76.34 | -500 | 23.2K | -2% | -$38.2K |
| D | 2025-01-16 | 2025-01-16 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $68.76 | -500 | 23.2K | -2% | -$34.4K |
| D | 2025-01-16 | 2025-01-16 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +500 | 23.7K | +2% | +$22.6K |
| D | 2024-12-16 | 2024-12-16 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $74.08 | -2,500 | 23.2K | -10% | -$185.2K |
| D | 2024-12-16 | 2024-12-16 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +2,500 | 25.7K | +11% | +$113.2K |
| D | 2024-07-11 | 2024-07-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $94.18 | -500 | 23.2K | -2% | -$47.1K |
| D | 2024-07-11 | 2024-07-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +500 | 23.7K | +2% | +$22.6K |
| 2024-07-08 | 2024-07-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | F - Tax | $92.32 | -410 | 23.2K | -2% | -$37.9K | |
| D | 2024-06-20 | 2024-06-20 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $45.28 | +535 | 24.0K | +2% | +$24.2K |
| D | 2024-06-20 | 2024-06-20 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $90.00 | -535 | 23.5K | -2% | -$48.1K |
| 2024-05-13 | 2024-05-11 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | F - Tax | $86.72 | -377 | 23.5K | -2% | -$32.7K | |
| DM | 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | A - Grant | $0.00 | +7,560 | 24.5K | +45% | $0 |
| D | 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $85.60 | -857 | 23.9K | -3% | -$73.4K |
| D | 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | F - Tax | $85.09 | -586 | 24.7K | -2% | -$49.9K |
| D | 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $36.75 | +857 | 25.3K | +4% | +$31.5K |
| M | 2024-05-06 | 2024-05-03+ | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | F - Tax | $85.16 | -572 | 16.9K | -3% | -$48.7K |
| D | 2024-04-09 | 2024-04-09 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $36.75 | +857 | 18.3K | +5% | +$31.5K |
| D | 2024-04-09 | 2024-04-09 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $92.34 | -857 | 17.5K | -5% | -$79.1K |
| D | 2024-03-07 | 2024-03-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $36.75 | +1,715 | 18.9K | +10% | +$63.0K |
| D | 2024-03-07 | 2024-03-07 | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $90.98 | -1,715 | 17.2K | -9% | -$156.0K |
| M | 2024-02-20 | 2024-02-16+ | EW | Edwards Lifesciences | Lippis Daniel J. | CVP, JAPAC | F - Tax | $86.08 | -545 | 17.6K | -3% | -$46.9K |
Purchase Sale Sale after option exercise All abbreviations